In addition, the inhibition of TGF-β signaling has been shown to reduce tumor growth and alleviate fibrosis in preclinical models of colorectal cancer [24], due to its trophic effect on tumor cells [25] and its profibrotic action [26]. The gene discussed is TGFB1; the disease is colorectal cancer.